For & Against

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

What's Next

The next six months are load-bearing for the thesis. Q4 FY26 results hit in mid-to-late May 2026 and Q1 FY27 lands in early August — together they are the referendum on whether the Dec-25 reacceleration ($45.5M, +20.7% YoY, the first quarter ever above $44.5M) was regime change or a one-quarter head-fake. Sell-side coverage is thin: only Prabhudas Lilladher is actively publishing, with a HOLD at $4.54 (roughly 7% upside); MarketsMojo sat at SELL on the same print. The market is watching one thing above all — does consolidated revenue stay above $44.5M into Q4 FY26 and Q1 FY27.

Current ($)

4.32

Street — Prabhudas HOLD

4.54

Bull Target — 18x FY27E EBITDA

6.12

Bear Downside — 12x peer EV/EBITDA

3.12

Catalyst calendar

No Results

What the market will watch most closely

The single most important data point is the Q4 FY26 revenue print in mid-May 2026. Management has publicly guided "stronger bottom line" — the bar is now set. A second consecutive quarter above $44.5M with India-engineering EBITDA above 18% reprices the multiple toward the post-IPO median of 35x. A revenue print back under $42.3M or a margin compression under 16% does the opposite — it crystallises the "one-quarter noise" read and opens the $3s on the downside.

Two secondary signals in the same window:

Romania Q4 FY26 EBITDA. Bull's thesis requires the Q4 FY25 $11.1M impairment to be the last mark-down. Bear's thesis sees the copper pass-through lag still feeding negative EBITDA. Two consecutive positive prints plus a $11.1M annualised Japanese run-rate is Bear's own stated covering signal.
Advantek breakeven disclosure. Guidance slipped from FY26 to Q1 FY27. Any further slippage confirms Bear's "next impairment candidate" framing; hitting the Q1 FY27 target neutralises it.

For / Against / My View

For

**Dec-25 broke the three-year coma.** Q3 FY26 printed $45.5M revenue, +20.7% YoY — the first quarter ever above $44.5M. Three of the five prior quarters posted +6.4%, +7.3%, +20.7% YoY, so the trend is accelerating, not one-off. Adjusted EBITDA grew 41.6% ex-labour-code provision. The stock has de-rated from 46x to 32x trailing while this was happening — the market has not yet marked the inflection.

**Promoter alignment is the strongest signal in the Indian mid-cap universe.** 75.00% holding — the SEBI regulatory maximum. Promoters moved from 74.61% → 75.00% in Sep-25 (net buyers three years after IPO, while the stock was 30%+ below its 2024 peak). Zero pledged shares. Zero secondary selling since the 2022 IPO OFS. Zero ESOPs, zero warrants, zero convertibles. Variable pay at 57–66% for the Gen-2 CEO and COO.

**The hidden growth engine — bushings went $0 → $11.4M in 5 years with a $13.0M signed LTA on top.** Bushings are a bronze-bearing adjacency that did not exist five years ago; management has publicly targeted $27.8–33.4M run-rate in three years. The signed $13.0M long-term contract kicks in from FY27-28 on top. In the same H1 FY26, large-size cages posted +285% YoY to $8.7M — the layered adjacencies are not in the bear's model.

Bull price target: $6.12 (+42%) on 18x EV/EBITDA × FY27E EBITDA of $31.7M, 12–18 month horizon. Disconfirming signal: consolidated revenue back under $42.3M or India-engineering segment EBITDA margin under 18%.

Against

**Three years of flat revenue at a 32x multiple.** Consolidated revenue has been stuck at $159–164M for three full fiscal years (FY23 → FY25), a two-year CAGR of 1.3%. Against that, the stock trades at 32.4x trailing P/E and 15.8x EV/EBITDA — multiples typically paid for 15%+ compounders. Dec-25 is one quarter of reacceleration layered on three years of stasis, and the market is extrapolating it before the print has a second data point.

**Peer-inferior returns priced at a peer premium.** FY25 ROCE of 10.7% and ROE of 7.1% sit at the bottom of the Indian bearings-complex peer set. SKF India earns 28.8% ROCE at 16.3x P/E. NRB Bearings earns 15.9% ROCE at 18.4x P/E. Menon Bearings earns 19.6% ROCE at 21.4x P/E. Harsha alone combines the lowest returns with the highest multiple — and ROE has declined every year since IPO (17.6% → 7.1%).

**$13.5M of realised write-offs from "strategic" bets — and the next one is visible.** Q4 FY25 took a $11.1M Romania investment impairment plus a $2.3M solar-EPC bad-debt write-off — combined ~130% of FY25 reported PAT. The next impairment candidate is already visible: Advantek greenfield at $29.3M of capex is running under 10% utilisation with a 9M-FY26 PAT loss of $1.0M, and the breakeven target has already slipped from FY26 to Q1 FY27.

Bear downside target: $3.12 (−28%) on 12x peer-average EV/EBITDA × normalised FY26E EBITDA of $20.6M, 12-month horizon. Covering signal: two consecutive Romania quarters with positive EBITDA above $0.56M and the Japanese customer crossing a $11.1M annualised run-rate.

The Tensions

1. The Dec-25 print — regime change or head-fake.

Bull says the $45.5M, +20.7% YoY print is the inflection, with the three-quarter sequence (+6.4%, +7.3%, +20.7%) showing acceleration, not a one-off. Bear says it is a single quarter of reacceleration layered on three years of stasis, helped by a labour-code-provision-aided base and copper pass-through. Both cite the same Q3 FY26 revenue and YoY figure. This resolves on the Q4 FY26 print in mid-May 2026 and the Q1 FY27 print in early August — two consecutive quarters above $44.5M make the inflection real; one print back under $42.3M kills it.

2. The 32x trailing multiple — priced for the old story or the new one.

Bull reads the 32x (down from 46x) as evidence the market has not yet marked the inflection — one clean forward quarter reprices toward the post-IPO median of 35x. Bear reads the same 32x as a peer-premium multiple paid for a business delivering peer-inferior ROCE (10.7% vs SKF 28.8%, NRB 15.9%, Menon 19.6%). Both cite the same P/E. This resolves on where FY27 EBITDA actually lands: Bull underwrites $31.7M (implying today's price is ~13x EV/EBITDA), Bear underwrites $20.6M (implying today's price is ~19x) — the Q4 FY26 and Q1 FY27 margin prints will tell the reader which side is pricing reality.

3. Romania $11.1M impairment and the $29.3M Advantek bet — cleansing event or pattern.

Bull reads the Q4 FY25 Romania $11.1M + solar $2.3M write-off as the last mark-down, after which there is "no incremental writedown inventory." Bear reads the same impairment as one data point in a serial-write-off pattern, with Advantek's $29.3M greenfield running under 10% utilisation and slipping from FY26 to Q1 FY27 breakeven as the next visible candidate. Both cite the same Q4 FY25 impairment line items. This resolves on the Q1 FY27 Advantek breakeven disclosure in August 2026 — a hit neutralises the pattern; a second slip confirms it.

My View

Close call, slight edge to the cautious side. The Against column has the concrete, peer-anchored number that is hardest to wave away — ROCE of 10.7% versus SKF India at 28.8% is not a narrative, it is the single sharpest indictment in the whole file, and no amount of bushing optionality yet offsets a four-year directional slide in returns on capital. The For column has the cleanest alignment signal available in Indian mid-caps (75% ceiling, zero pledge, zero selling) and a genuine adjacency engine in bushings, but both require two more clean prints to translate into reprice-able reality. The resolving tension is tension #1 — one more quarter above $44.5M with India-engineering EBITDA above 18% flips the view, because it validates both the Dec-25 read and the forward-EBITDA path that makes the 32x multiple cheap rather than expensive. Until that Q4 FY26 print (mid-May, roughly three weeks out), I would wait rather than initiate — the cost of being late by one quarter is small compared to the cost of catching a head-fake. Lean cautious, not bearish: the promoter signal and the bushing LTA mean the downside is supported; the absence of a second data point means the upside is unproven.